AlphaCentric Advisors’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6,250	Closed	-$2.24M	–	280
2024 Q3	$2.24M	Sell	6,250 -8,250	-57%	-$2.79M	1.67%	14
2024 Q2	$4.62M	Sell	14,500 -1,500	-9%	-$397K	3.4%	1
2024 Q1	$3.68M	Buy	+16,000	New	+$3.61M	2.22%	4
2023 Q4	–	Sell	-9,000	Closed	-$2.03M	–	283
2023 Q3	$2.03M	Hold	9,000	–	–	1.15%	26
2023 Q2	$1.99M	Buy	9,000 +5,500	+157%	+$1.22M	1.1%	26
2023 Q1	$784K	Buy	3,500 +1,250	+56%	+$308K	0.54%	66
2022 Q4	$626K	Hold	2,250	–	–	0.62%	60
2022 Q3	$471K	Buy	+2,250	New	+$503K	0.48%	59
2021 Q4	$238K	Buy	1,100 +550	+100%	+$108K	0.07%	96
2021 Q3	$102K	Hold	550	–	–	0.03%	163
2021 Q2	$99K	Hold	550	–	–	0.03%	172
2021 Q1	$92K	Sell	550 -200	-27%	-$33.3K	0.03%	162
2020 Q4	$114K	Sell	750 -76	-9%	-$9.97K	0.05%	109
2020 Q3	$83K	Buy	+826	New	+$90.6K	0.04%	71